Morabito Christopher
- SEC CIK
- 0001859284
No open-market purchases or sales filed in the past year.
Current role at each company
- ATXS Astria Therapeutics, Inc.Chief Medical Officeras of Jan 23, 2026
- FULC Fulcrum Therapeutics, Inc.Chief Medical Officeras of Jan 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Morabito Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATXS Astria Therapeutics, Inc.
Chief Medical Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Morabito ChristopherChief Medical Officer | SSale | −10.0K | $13.59 | −$135.9K | −100.0%0 after | 10b5-1 |
| Jan 30, 2024 (view filing) | Jan 26-29 | 4 days | Morabito ChristopherChief Medical Officer | SSale | −10.0K | $11.14 | −$111.4K | −100.0%0 after | 2 lots10b5-1 |